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hospital environment and show strongly ex-
pressed antibacterial multi-drug resistance. 
These facts impose a special approach to 
their diagnosis and treatment 
The aims of this study were: i) to 
define the frequency of M R S in clinical 
specimens, and ii) to compare their sen-
sibility in vitro to some antibacterial drugs 
applied in the therapeutic schemes. 
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Methicillin/oxacillin resistant Staphylococci (MRS) cause high morbility and 
mortality. The aim of the present study is to determine the incidence rate of MRS among 
clinical specimens and to study in vitro their sensitivity to some antibacterial drugs 
most often applied in therapeutic schedules. A total of 104 Staphylococcus strains 
were isolated. Of them, 66,35 % were Staphylococcus aureus and 33,65 % were co-
agulase-negative staphylococci (CNS). MRS were 33,65 % of all the strains. Of them, 
45,71 % were MRSA and 54,29 % were MRCNS. In the clinical material they were 
distributed as followed: 62,85 % from nasopharyngeal swabs, 14,28 % from blood 
cultures, 5,73 % from expectorated sputum, terminal urine and vaginal swabs, and 
2,86 % from ear swabs and vascular catheters. MR was due to hyperproduction of 
normal staphylococcic penicillinase by 27 strains. Six strains contained in their chro-
mosome gene mec A responsible for the synthesis of imperfect penicillin-binding pro-
tein. Some 12,5 % of MRSA and 11,8 % of MRCNS were resistant to gentamycin, 15,8 
% of MRCNS - to ciprofloxacin, 12,5 % of MRSA and 21,1 % of MRCNS - to rifamycin 
and 21,1 % of MRCNS - to imipenem. The frequency of MRS strains was within mean 
values for the country. In-vitro sensitivity could assist the complex treatment of Staphy-
lococcus infections. 
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Methicillin-resistant Staphylococ-
cus strains ( M R S ) are one of the most 
important bacteria nowadays. They are 
distinguished by heterogeneity of popula-
tion, high virulence and great epidemic 
rates. M R S are difficult to eliminate from 
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MATERIAL AND METHODS 
A total of 104 Staphylococcus 
strains were included in the study. They 
were isolated from nasopharyngeal swabs 
(73 strains), expectorated sputum (6 
strains), blood cultures (5 strains), termi­
nal urine (4 strains), vaginal swabs (4 
strains), gall-bladder swabs (2 strains), 
wound swabs (2 strains), urethral swabs 
(2 strains), ear swabs, abdominal fluids, 
pleural fluid, bronchial fluid, conjunctival 
swabs and vascular catheter 1 strain each. 
Detection of oxacillin resistance 
Parallelly to the conventional disc diffusion 
method with oxacillin discs, agar dilution 
method for susceptibility testing to 2,4,8, 
16,32 and 64 mg/L oxacillin+4 % NaCl 
in Mueller-Hinton agar and test microor­
ganisms 5. aureus 29213 A T C C (sensi­
tive strain), 5. aureus 33592 A T C C (re­
sistant strain) was performed. The strains 
were defined as borderline (< 2 mg/L), 
intrinsic (> 16mg/L), and intermediate (4-
8 mg/L) (3). Testing of antibacterial sus­
ceptibility of M R S A in vitro to gentamycin, 
ciprofloxacin, and rifamycin (Pharmacia, 
Bulgaria) and to imipenem (Merck) was 
done by the method determining their 
Minimal Inhibitory Concentration (MIC) 
(by N C C L S , 1993) using a twofold se­
rial dilution in Mueller-Hinton agar and a 
Steers type inoculation (11). 
RESULTS AND DISCUSSION 
The comparative distribution of 
104 Staphylococcus strains into M R S , 
M S S , M R S A , M S S A , M R C N S and 
M S C N S is shown on Fig . 1. The distri-
n=69 n=35 n=104 
S. aureus CNS Staphylococcus 
Fig. 1. The relative share of MRSA and MRCNS of Staphylococcus's strains 
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1 - 62,85 % - nasopharyngeal swabs 
2 -14,28 % - blood cultures 
3 - 5,73 % - sputum 
4 - 5,73 % - terminal urine 
5 - 5,73 % - vaginal swabs 
6 - 2,86 % - ear swabs 
7 - 2,86 % - vascular catheters 
4g. 2. The relative share of MRS in clinical specimens 
ib l e l 
itibacterial activity of oxacillin defined by using twofold serial dilutions of MRS in 
linical specimens 
MIC (mg/L) 2 4 8 16 32 64 
Total number of strains (n= 35) 27 2 1 5 
Antibacterial activity borderline intermediate intrinsic resistant 
ible2 
MIC of 35 MRS to some antibacterial drugs (mg/L) 
Antibiotics MIC range MIC 50 MIC 90 
Imipenem 0,007 - 2 
Gentamycin 0,007 - 32 
Ciprofloxacin 0,007 - 2 
Rifamycin 0,015 - 8 
tion of M R S in clinical specimens is i l -
strated on Fig . 2. The antibacterial ac-
tivity to oxacillin is presented in Table 1. 
Twenty-seven strains are identified as bor-
derline, two are intermediate, and six are 
with intrinsic resistance. M I C of 35 M R S 
some antibacterial drugs can be seen 





M I C 5 0 and M I C 9 0 for gentamycin, 
ciprofloxacin, rifamycin and imipenem of 
M R S A and M R C N S . 
An epidemiological study pursued 
in some European countries showed vari-
ous rates of M R S isolation. This study in-
dicated that at an average for Europe 60 
% from all of Staphylococcus infections 
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1 2 3 4 
• S.aureus 100 87,5 100 87,5 
В CNS 78,9 84,2 84,2 78,9 
Fig. 3. Susceptibility of MRSA and MRCNS to some antibacterial drugs 
were due to M R S A . In Bulgaria, about 
20 % of Staphylococcus strains are M R 
(data of 1996) (4). Some authors reported 
different data about the frequency of 
M R S . The results from other University 
laboratories in our country were: 8 % for 
Plovdiv, 19% for "Tsaritsa Johanna" State 
University Hospital - Sofia (4), more than 
20 % for Stara Zagora (1), and 26 % for 
Medical University-Sofia (8). The relative 
share of M R S established in this study 
nearly approached the data of authors 
from Greece, Italy, and Spain, as well as 
for the towns of Sliven, Razgrad, and Ruse 
(4). The relatively high results for our 
strains were probably due to the prevail­
ing number of M R C N S . Their detection 
in some test materials may be explained 
with contamination. The relative share of 
M R S A in the Varna University Hospital 
for this period was on the average for the 
country. 
The study of mechanisms of me-
thicillin/oxacillin resistance establishes that 
it is due to hyperproduction of normal Sta­
phylococcus penicillinase in greater part 
of the strains - 27. These cultures possess 
low resistance rate. Their detection and 
differentiation is very important. They can 
be influenced by penicillins combined with 
beta-lactam inhibitors. The large number 
of borderline M R S detected is to some 
extent a "favourable" result, although their 
clinical interpretation with respect to pa­
tients is this as of intrinsic resistant Sta­
phylococci (4). It is known that high lev­
els of resistance are due to the production 
of an additional high-molecular penicillin-
binding protein 2a (PBP-2a). It is coded 
by gene mec A which is absent in sensi­
tive strains. The gene is identical in all cul­
tures. Staphylococcus aureus expression 
of methicillin/oxacillin resistance is con­
trolled not only by transcription and trans-
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them in therapeutic schedules in suitable 
combinations especially for mild M R S in­
fections. Their use should be very careful 
as it was already reported about rapid 
development of multi-drug resistance to 
them in vivo (2,3,10). 
In conclusion, these results 
showed that the distribution of M R S in 
clinical specimens was within average rates 
for the country. Their susceptibility to some 
antibacterial drugs established in vitro al­
lowed their incorporation in the therapeu­
tic schedules in combination with glyco-
peptides. 
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lation of mec A gene, but also by a great 
number of chromosomal genes (5). In the 
present study six intrinsic strains were iso­
lated, i . е., a genetically determined resis­
tance. 
The studies of antibacterial sensi­
tivity in vitro showed multi-drug resistance 
for some of the strains. Compared to data 
reported by other authors, our results dem­
onstrated higher sensitivity to gentamycin 
(2,6), but higher resistance to rifamycin and 
ciprofloxacin (2,9), along with similar re­
sults about sensitivity to imipenem (1). 
Probably, these differences were due to 
the various origin of compared strains and 
the antibacterial therapy used in hospitals, 
respectively. Susceptibility proved in vitro 
to gentamycin, ciprofloxacin, rifamycin, 
and imipenem also pointed by other au­
thors (7,12) was the reason to include 
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Метицилин-резистентни стафилококи - разпространение в 
клинични изолати и in vitro чувствителност към някои 
антимикробни средства 
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Резюме: Метицилин-резистентните стафилококи (MRS) причиняват висока 
заболеваемост и смъртност, отличават се с особено голяма епидемичност и имат 
силно изразена лекарствена полирезистентност. Те са едни от най-честите причинители 
на вътреболничните инфекции. Цел на настоящото проучване е да се определи 
честотата на MRS сред клиничните изолати и in vitro чувствителността им към най-
често прилаганите в терапевтичните схеми антимикробни средства. Изолирани са 
104 стафилококови щама, от които 66,35 % са S.aureus и 33,65 % са коагулаза-негативни 
стафилококи (CNS). По материали се разпределят така: 70 % от носно-гърлени секрети, 
5,77 % от храчки, 4,81 % от хемокултури, по 3,85 % от урини и влагалищни секрети и 
единични щамове от жлъчен сок, раневи, ушни и бронхиални секрети, коремен и 
плеврален пунктати, съдов катетър и др. Метицилин-резистентните стафилокококи 
са 33,65 % от всички изолирани щамове. От тях 45,7 1% са MR S.aureus и 54,29 % са 
MRCNS. Метилициновата резистентност се дължи на хиперпродукция на нормална 
стафилококова пенициалиназа при 4 от щамовете. Стафилококовите изолати, 
съдържащи в хромозомата си ген-mec А, отговарящ за синтеза на дефектния 
пеницилин-свързващ протеин, са 6. Към Gentamycin са резистентни 14,28 % от MRS, 
към Ciprofloxacin - 8,51 %, към Rifampicin - 17,14 %, към Imipenem - 11,43 % и към 
Mupirocin - 2,86 %. Описват се клинико-микробиологичните характеристики на няколко 
полирезистентни MRS щама. 
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